Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MOR

MorphoSys

$26.00

-0.48 (-1.81%)

09:22
05/20/19
05/20
09:22
05/20/19
09:22
Recommendations
MorphoSys analyst commentary at Piper Jaffray »

Piper remains bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

  • 07

    Aug

Thursday
MOR

MorphoSys

$26.24

1.4 (5.64%)

19:39
05/16/19
05/16
19:39
05/16/19
19:39
Recommendations
MorphoSys analyst commentary at Piper Jaffray »

MorphoSys L-MIND data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

  • 07

    Aug

MOR

MorphoSys

$26.24

1.4 (5.64%)

19:26
05/16/19
05/16
19:26
05/16/19
19:26
Hot Stocks
MorphoSys confirms primary endpoint of L-MIND study was met »

MorphoSys AG announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

  • 07

    Aug

Over a week ago
MOR

MorphoSys

$24.68

-0.1 (-0.40%)

04:55
04/25/19
04/25
04:55
04/25/19
04:55
Conference/Events
MorphoSys management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 20

    Jun

MOR

MorphoSys

$24.78

0.7 (2.91%)

04:55
04/24/19
04/24
04:55
04/24/19
04:55
Conference/Events
MorphoSys management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

  • 20

    Jun

GLPG

Galapagos NV

$114.88

0.61 (0.53%)

, MOR

MorphoSys

$24.78

0.7 (2.91%)

16:06
04/23/19
04/23
16:06
04/23/19
16:06
Hot Stocks
Galapagos NV, MorphoSys and Novartis announce GECKO study initiation »

Galapagos NV (GLPG),…

GLPG

Galapagos NV

$114.88

0.61 (0.53%)

MOR

MorphoSys

$24.78

0.7 (2.91%)

NVS

Novartis

$76.01

0.585 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 08

    May

  • 23

    May

  • 31

    May

  • 20

    Jun

Over a month ago
MOR

MorphoSys

$24.75

-0.16 (-0.64%)

06:37
04/18/19
04/18
06:37
04/18/19
06:37
Conference/Events
MorphoSys management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

MOR

MorphoSys

$22.70

(0.00%)

09:33
04/02/19
04/02
09:33
04/02/19
09:33
Upgrade
MorphoSys rating change at Berenberg »

MorphoSys upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

MOR

MorphoSys

$23.55

-0.165 (-0.70%)

17:13
03/19/19
03/19
17:13
03/19/19
17:13
Hot Stocks
MorphoSys, I-Mab Biopharma initiate phase 2 study of TJ202 for multiple myeloma »

China-based I-Mab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 08

    May

MOR

MorphoSys

$25.83

-0.14 (-0.54%)

20:38
02/27/19
02/27
20:38
02/27/19
20:38
Recommendations
MorphoSys analyst commentary at Piper Jaffray »

Piper Jaffray more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 24

    Apr

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.